Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Latigo Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.00	0.00	-0.01
Debt / EBITDA Ratio	0.00	-0.01	-0.01
Debt / FCF Ratio	-0.01	-0.01	-0.02
Net Debt / Equity Ratio	0.17	0.30	0.13
Net Debt / EBITDA Ratio	0.37	0.62	0.27
Net Debt / FCF Ratio	0.40	0.71	0.33
Quick Ratio	2.92	3.77	1.24
Return on Equity (ROE)	44.02%	47.12%	47.21%
Return on Assets (ROA)	-	-144.56%	-267.60%
Return on Invested Capital (ROIC)	-	-337.08%	-752.77%
Return on Capital Employed (ROCE)	787.22%	-196.44%	-752.72%